Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NX Gen
Grand Rapids, Michigan, United Statesnxgenmdx.com ↗
- Ownership
- Private
- Employees
- ~150
- Development stage
- Other
01
Overview
NxGen MDx is a leading women's health genetic testing company that provides actionable diagnostic information to physicians and patients. The company specializes in advanced screening technologies, including carrier screening, hereditary cancer testing, and prenatal diagnostics, utilizing high-throughput next-generation sequencing (NGS). By focusing on accuracy and accessibility, NxGen MDx aims to empower families with genetic insights to guide reproductive and health management decisions. Their clinical laboratory is CLIA-certified and CAP-accredited, ensuring high standards for molecular diagnostic services.
- Therapeutic areas
- OncologyNeurologyWomen's HealthPulmonology
- Modalities
- Genetic testingNext-generation sequencingMolecular diagnostics
- Industry
- Molecular Diagnostics
Beyond the preview
Go deeper on NX Gen.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NX Gen.